Depression and Anxiety Trial, Recruiting NCT06526260 Sponsor: Children's Hospital Los Angeles Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06526260
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For young people with Social Anxiety Disorder (patient group):

  • People aged 16 to 22 who have been diagnosed with Social Anxiety Disorder (a condition involving intense fear of social situations), confirmed through a standardised clinical interview
  • People whose primary language is English or Spanish

For healthy young people (comparison group):

  • People aged 16 to 22 without a history of anxiety or other psychiatric conditions
  • People whose primary language is English or Spanish

For parents/caregivers:

  • Parents or caregivers of any age who speak English or Spanish fluently, with no other restrictions on eligibility

Who may not be able to join:

For young people with Social Anxiety Disorder (patient group):

  • People who are currently experiencing active thoughts of suicide, including plans or intentions, as measured by a standard safety scale
  • People who have metal implants (such as a pacemaker), metal braces, retainers, tattoos or permanent make-up containing metal, or medical skin patches that cannot be removed (these are safety concerns for MRI scanning)
  • People currently taking any psychiatric or psychoactive medications
  • People who have ever been diagnosed with OCD, a psychotic disorder, bipolar disorder, autism spectrum disorder, or intellectual disability
  • People who have any serious neurological or medical conditions (such as lupus, cancer, or HIV), as reported by the participant
  • People who currently have a diagnosis of Post-Traumatic Stress Disorder (PTSD)
  • People who currently have a severe substance use problem (not including tobacco or nicotine)
  • People who are pregnant at the time of the MRI scan, based on self-report

For healthy young people (comparison group):

  • People who have ever been diagnosed with any anxiety disorder, OCD, a psychotic disorder, bipolar disorder, autism spectrum disorder, or intellectual disability
  • People who have had any psychiatric disorder in the past two years
  • People who currently have depression
  • People who have any serious neurological or medical conditions
  • People currently taking any psychiatric or psychoactive medications
  • People who have metal implants, metal braces, retainers, tattoos or permanent make-up containing metal, or medical skin patches that cannot be removed
  • People who are currently experiencing active thoughts of suicide, including plans or intentions
  • People who are pregnant at the time of the MRI scan, based on self-report

For parents/caregivers:

  • People whose primary language is not English or Spanish

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bradley S Peterson, MD, Children's Hospital Los Angeles

Phone: 323-361-6456

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital Los Angeles
Registry
ClinicalTrials.gov
Start date
14 August 2024
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean Activation of Frontostriatal and Prefrontal Brain Regions to disgusted facial expression in Social Anxiety; Mean activation of regions subserving emotion, emotion regulation, and attention processing. Mean deactivation of the Default Mode Network.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov